PhoenixBio Co.,Ltd.
株式会社フェニックスバイオ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 6190
FY2025 · 2026-03-31
| Gross margin | 76.7% |
| Operating margin | 5.3% |
| Net margin | 8.0% |
| Return on equity | 8.6% |
| Return on assets | 5.7% |
| Revenue growth (YoY) | 1.6% |
| EPS (basic) | ¥30.81 |
| EPS growth (YoY) | — |
| Current ratio | 4.40x |
| Equity ratio | 66.6% |
| Book value / share | ¥377.94 |
| Free cash flow | 56 M |